Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company that is one of the largest generic drug manufacturers in the world. The company was founded in 1901 in Jerusalem, during the Ottoman Empire, by Chaim Salomon, Yitschak Elstein, and Moshe Levin. It initially operated as a small wholesale drug distributor, but over the years, it expanded its operations and became a prominent player in the global pharmaceutical industry.
Teva's core business is the development, production, and distribution of a wide range of generic and specialty pharmaceutical products. The company focuses on producing high-quality, affordable medicines that are used to treat various medical conditions, including cardiovascular diseases, central nervous system disorders, respiratory illnesses, and oncology treatments.
As a global pharmaceutical company, Teva has a significant presence in various markets worldwide. The company has production facilities and subsidiaries in numerous countries, allowing it to serve a diverse customer base across different regions.
Throughout its history, Teva has faced both successes and challenges. It has played a crucial role in making essential medicines more accessible and affordable to patients globally through its generic drug offerings. However, the company has also faced legal and financial issues, including patent disputes and debt challenges, which have impacted its financial performance over time